Robert N. Brey

1.7k total citations
30 papers, 1.4k citations indexed

About

Robert N. Brey is a scholar working on Immunology, Molecular Biology and Biotechnology. According to data from OpenAlex, Robert N. Brey has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 14 papers in Molecular Biology and 12 papers in Biotechnology. Recurrent topics in Robert N. Brey's work include Transgenic Plants and Applications (12 papers), Toxin Mechanisms and Immunotoxins (12 papers) and Bacillus and Francisella bacterial research (4 papers). Robert N. Brey is often cited by papers focused on Transgenic Plants and Applications (12 papers), Toxin Mechanisms and Immunotoxins (12 papers) and Bacillus and Francisella bacterial research (4 papers). Robert N. Brey collaborates with scholars based in United States, Switzerland and United Kingdom. Robert N. Brey's co-authors include Barry P. Rosen, Nicholas J. Mantis, Joanne M. O’Hara, Jeanne C. Beck, Erik N. Sorensen, Lori M. Neal, Stanley J. Cryz, Jonathan T. Ou, William R. Majarian and Wayne T. Hockmeyer and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Robert N. Brey

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert N. Brey United States 19 661 474 355 208 205 30 1.4k
Yoko Yasuda Japan 23 675 1.0× 274 0.6× 173 0.5× 178 0.9× 213 1.0× 73 1.4k
Suzanne R. Kalb United States 31 616 0.9× 374 0.8× 158 0.4× 151 0.7× 176 0.9× 69 2.3k
Kunio Tochikubo Japan 21 457 0.7× 281 0.6× 162 0.5× 212 1.0× 283 1.4× 67 1.2k
Marcelo E. Guerin Spain 26 1.5k 2.2× 216 0.5× 294 0.8× 482 2.3× 211 1.0× 79 2.2k
Bernadette Coddeville France 24 1.4k 2.1× 413 0.9× 182 0.5× 417 2.0× 147 0.7× 56 2.2k
Joe Tiralongo Australia 22 1.0k 1.5× 284 0.6× 76 0.2× 134 0.6× 89 0.4× 67 1.6k
Olga Kandror United States 17 1.3k 2.0× 162 0.3× 148 0.4× 303 1.5× 301 1.5× 20 1.9k
Alejandro Buschiazzo France 33 2.2k 3.3× 438 0.9× 258 0.7× 200 1.0× 484 2.4× 82 3.3k
Yôko Shôji Japan 21 797 1.2× 205 0.4× 466 1.3× 264 1.3× 95 0.5× 63 1.5k
K. Michalska United States 22 989 1.5× 136 0.3× 163 0.5× 412 2.0× 115 0.6× 53 1.8k

Countries citing papers authored by Robert N. Brey

Since Specialization
Citations

This map shows the geographic impact of Robert N. Brey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert N. Brey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert N. Brey more than expected).

Fields of papers citing papers by Robert N. Brey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert N. Brey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert N. Brey. The network helps show where Robert N. Brey may publish in the future.

Co-authorship network of co-authors of Robert N. Brey

This figure shows the co-authorship network connecting the top 25 collaborators of Robert N. Brey. A scholar is included among the top collaborators of Robert N. Brey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert N. Brey. Robert N. Brey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Evans, David J., et al.. (2018). Seneca Valley Virus Exploits TEM8, a Collagen Receptor Implicated in Tumor Growth. Frontiers in Oncology. 8. 506–506. 22 indexed citations
3.
Brey, Robert N., Nicholas J. Mantis, Seth H. Pincus, et al.. (2016). Recent advances in the development of vaccines against ricin. Human Vaccines & Immunotherapeutics. 12(5). 1196–1201. 12 indexed citations
4.
Pincus, Seth H., Manoj Bhaskaran, Robert N. Brey, et al.. (2015). Clinical and Pathological Findings Associated with Aerosol Exposure of Macaques to Ricin Toxin. Toxins. 7(6). 2121–2133. 44 indexed citations
5.
Vance, David J., Yinghui Rong, Robert N. Brey, & Nicholas J. Mantis. (2014). Combination of two candidate subunit vaccine antigens elicits protective immunity to ricin and anthrax toxin in mice. Vaccine. 33(3). 417–421. 11 indexed citations
6.
Iyer, Vidyashankara, Lei Hu, David J. Vance, et al.. (2013). Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccine. Human Vaccines & Immunotherapeutics. 9(11). 2362–2370. 8 indexed citations
7.
Greene, Casey S., Chrystal Chadwick, Joanne M. O’Hara, et al.. (2013). LT-IIb(T13I), a Non-Toxic Type II Heat-Labile Enterotoxin, Augments the Capacity of a Ricin Toxin Subunit Vaccine to Evoke Neutralizing Antibodies and Protective Immunity. PLoS ONE. 8(8). e69678–e69678. 12 indexed citations
8.
Hassett, Kimberly J., Lilia A. Rabia, Chrystal Chadwick, et al.. (2013). Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization. European Journal of Pharmaceutics and Biopharmaceutics. 85(2). 279–286. 39 indexed citations
9.
Thomas, Justin C., Joanne M. O’Hara, Lei Hu, et al.. (2013). Effect of single-point mutations on the stability and immunogenicity of a recombinant ricin A chain subunit vaccine antigen. Human Vaccines & Immunotherapeutics. 9(4). 744–752. 11 indexed citations
10.
Legler, Patricia M., Robert N. Brey, Joan E. Smallshaw, Ellen S. Vitetta, & Charles B. Millard. (2011). Structure of RiVax: a recombinant ricin vaccine. Acta Crystallographica Section D Biological Crystallography. 67(9). 826–830. 27 indexed citations
11.
O’Hara, Joanne M., et al.. (2010). Folding domains within the ricin toxin A subunit as targets of protective antibodies. Vaccine. 28(43). 7035–7046. 64 indexed citations
12.
Neal, Lori M., Joanne M. O’Hara, Robert N. Brey, & Nicholas J. Mantis. (2009). A Monoclonal Immunoglobulin G Antibody Directed against an Immunodominant Linear Epitope on the Ricin A Chain Confers Systemic and Mucosal Immunity to Ricin. Infection and Immunity. 78(1). 552–561. 65 indexed citations
13.
Peek, Laura J., Robert N. Brey, & C. Russell Middaugh. (2006). A Rapid, Three-Step Process for the Preformulation of aRecombinant Ricin Toxin A-Chain Vaccine. Journal of Pharmaceutical Sciences. 96(1). 44–60. 36 indexed citations
14.
Brey, Robert N.. (2005). Molecular basis for improved anthrax vaccines. Advanced Drug Delivery Reviews. 57(9). 1266–1292. 79 indexed citations
15.
Clark, M. Ann, et al.. (2001). Targeting polymerised liposome vaccine carriers to intestinal M cells. Vaccine. 20(1-2). 208–217. 109 indexed citations
16.
Dilts, Deborah A., Erik Ekwall, Carl Granert, et al.. (2000). Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity. Vaccine. 18(15). 1473–1484. 32 indexed citations
17.
Brey, Robert N.. (1995). Development of Vaccines Based on Formulations Containing Nonionic Block Copolymers. Pharmaceutical biotechnology. 6. 297–311. 10 indexed citations
18.
Brey, Robert N., et al.. (1991). Oral Delivery of Antigens in Live Bacterial Vectors. Advances in experimental medicine and biology. 303. 169–184. 14 indexed citations
19.
Brey, Robert N. & Barry P. Rosen. (1979). Cation/proton antiport systems in Escherichia coli. Properties of the calcium/proton antiporter.. Journal of Biological Chemistry. 254(6). 1957–1963. 146 indexed citations
20.
Brey, Robert N. & Barry P. Rosen. (1979). Properties of Escherichia coli mutants altered in calcium/proton antiport activity. Journal of Bacteriology. 139(3). 824–834. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoko Yasuda Breakdown of academic impact, for papers by Suzanne R. Kalb Breakdown of academic impact, for papers by Kunio Tochikubo Breakdown of academic impact, for papers by Marcelo E. Guerin Breakdown of academic impact, for papers by Bernadette Coddeville Breakdown of academic impact, for papers by Joe Tiralongo Breakdown of academic impact, for papers by Olga Kandror Breakdown of academic impact, for papers by Alejandro Buschiazzo Breakdown of academic impact, for papers by Yôko Shôji Breakdown of academic impact, for papers by K. Michalska
Rankless by CCL
2026